Trial for keeping weight off after stopping GLP-1 meds
Treatments studied
Part of Hormones & metabolism clinical trials.
This study tests if other medicines (naltrexone, metformin, or rapamycin) can help people keep off weight they lost while taking GLP-1 drugs like Wegovy or Ozempic, after they stop taking them. It is for AgelessRx patients aged 40 to 85 who have lost at least 15 pounds on GLP-1s.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an existing patient of AgelessRx.
- You are between 40 and 85 years old.
- Your BMI is 22 or higher.
- You have been taking GLP-1 drugs (Wegovy, Ozempic, or compounded forms) for at least three months.
- You have lost at least 15 pounds while using GLP-1 drugs.
- You do not have a history of weight-loss surgery or have not used other weight-loss drugs in the past six months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a 6-month behavioral program to help people keep off the weight they lost using GLP-1 or other weight-loss medications after they stop taking those medications. The program includes a 10-week foundational course, virtual sessions, and support to help you maintain your weight loss.
This trial tests whether a daily probiotic supplement can help people maintain their weight after they stop taking a GLP-1 medication (like Ozempic or Wegovy). It aims to see if the probiotic helps keep the weight off.
This trial tests whether a very low ('micro') dose of semaglutide can improve health, quality of life, and how long you live well. It's for people who are interested in the drug's general health benefits but not specifically for weight loss.
This study tests whether a newer class of weight-loss medicines (GLP-1 and GIP/GLP-1 analogues) can help people with excess body weight eat healthier and improve their metabolism and behavior. It may be a good option if you are an adult with overweight or obesity and haven't used these medicines recently.
This study looks at how a medical weight-loss program affects your body's aging process. If you are enrolled in the NOVI OP+ program, you may help us understand whether losing weight can slow biological aging.
This trial compares different ways to keep weight off after you've lost weight using a GLP-1 medication, like semaglutide or tirzepatide. It tests reducing your GLP-1 dose and adding other weight loss medications to help maintain your progress.
Hear when a new Longevity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.